Answers are grounded in this paper and cite their sources.
Introduction: lidocaine is a drug belonging to the local anesthetics, it is rapidly distributed in the body andmetabolized in the liver. At commonly recommended doses, the therapeutic index of lidocaine remains very highand plasma concentrations remain largely below neurotoxic, cardiotoxic and other thresholds. It is used duringvarious medical procedures, and in the nervous system it acts by binding to a specific site which is the sodiumchannel receptor of the neural membrane and blocking the passage of ions.Objective: to determine the potential usefulness of lidocaine in neonates with convulsive syndrome.Methods: in the present systematic review we tried to provide an answer and conducted a literature searchthrough pubmed and others to analyze the usefulness of lidocaine in neonatal convulsive syndrome and itspotential benefit.Results: after applying the inclusion and exclusion criteria, we will be able to identify the groups of neonates athigher risk and the efficacy of lidocaine treatment.Conclusions: lidocaine is the third drug used in neonatal convulsive syndrome for maintenance where theyreceive it in continuous infusion, being effective in suppressing electro-clinical crises. Excessive doses oflidocaine should be avoided since it can produce convulsions and other adverse effects in children
No takes yet. Share an insight, caveat, or question.
Milange et al. (2024) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: